Clinical Research Directory
Browse clinical research sites, groups, and studies.
HPV Ends Here: Increasing Uptake of the HPV Vaccine
Sponsor: University of California, Davis
Summary
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
Official title: Human Papillomavirus Ends Here: A Multilevel Intervention to Increase Uptake of the HPV Vaccine Among Adolescents
Key Details
Gender
All
Age Range
10 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
2232
Start Date
2025-02-28
Completion Date
2026-12-31
Last Updated
2025-04-25
Healthy Volunteers
Yes
Conditions
Interventions
Intervention Arm
Within the intervention clinics, parents of patients between the ages of 10-12 (who are eligible for the HPV vaccine) will receive a culturally tailored customized HPV vaccine message and testimonial video from a patient/survivor of an HPV associated cancer (e.g., oropharyngeal, or cervical) via the MyChart patient portal. Parents will also receive a personal call from the research coordinator to remind them that their child is due for the HPV vaccine. If the parent is interested in scheduling the HPV vaccine appointment during this call, the research coordinator will transfer the parent to UC Davis appointment call center to schedule the appointment. Also, primary care team members will receive a semi-annual learn at lunch workshop focused on strategies to introduce the HPV vaccine to parents and how to address concerns from vaccine hesitant parents. Workshop content will be tailored/adapted to include patient/parent cultural considerations.
Locations (1)
University of California Davis Health
Sacramento, California, United States